This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimpton, J
Right arrow Articles by Emerman, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimpton, J
Right arrow Articles by Emerman, M

 Previous Article  |  Next Article 

J Virol. 1992 April; 66(4): 2232-2239

Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

J Kimpton and M Emerman

Program in Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

ABSTRACT

We have constructed a HeLa cell line that both expresses high levels of CD4 and contains a single integrated copy of a beta-galactosidase gene that is under the control of a truncated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR). This cell line, called CD4-LTR/beta-gal, can be used to determine quantitatively the titer of laboratory-adapted HIV strains, and the method used to do so is as sensitive as the determination of viral titers in a T-cell line by end point dilution. Using this cell line as a titer system, we calculated that HIV-1 stocks contain only one infectious particle per 3,500 to 12,000 virions. Virus derived from a molecular clone of a macrophagetropic provirus will not infect this cell line. We have also cocultivated peripheral blood lymphocyte cultures from HIV-infected individuals with the CD4-LTR/beta-gal indicator cells. In a majority of primary isolates (five of eight), including isolates from asymptomatic patients, rare virus-infected cells that can activate the beta-galactosidase gene are present.

J Virol. 1992 April; 66(4): 2232-2239




This article has been cited by other articles:

  • Moreno-Fernandez, M. E., Zapata, W., Blackard, J. T., Franchini, G., Chougnet, C. A. (2009). Human Regulatory T Cells Are Targets for Human Immunodeficiency Virus (HIV) Infection, and Their Susceptibility Differs Depending on the HIV Type 1 Strain. J. Virol. 83: 12925-12933 [Abstract] [Full Text]  
  • Levin, A., Hayouka, Z., Brack-Werner, R., Volsky, D. J., Friedler, A., Loyter, A. (2009). Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration. Protein Eng Des Sel 22: 753-763 [Abstract] [Full Text]  
  • Lim, E. S., Emerman, M. (2009). Simian Immunodeficiency Virus SIVagm from African Green Monkeys Does Not Antagonize Endogenous Levels of African Green Monkey Tetherin/BST-2. J. Virol. 83: 11673-11681 [Abstract] [Full Text]  
  • Zychlinski, D., Erkelenz, S., Melhorn, V., Baum, C., Schaal, H., Bohne, J. (2009). Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure. Nucleic Acids Res 0: gkp694v1-gkp694 [Abstract] [Full Text]  
  • Jaber, T., Bohl, C. R., Lewis, G. L., Wood, C., West, J. T. Jr., Weldon, R. A. Jr. (2009). Human Ubc9 Contributes to Production of Fully Infectious Human Immunodeficiency Virus Type 1 Virions. J. Virol. 83: 10448-10459 [Abstract] [Full Text]  
  • Etemad, B., Fellows, A., Kwambana, B., Kamat, A., Feng, Y., Lee, S., Sagar, M. (2009). Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection. J. Virol. 83: 9694-9708 [Abstract] [Full Text]  
  • Iyer, S. R., Yu, D., Biancotto, A., Margolis, L. B., Wu, Y. (2009). Measurement of Human Immunodeficiency Virus Type 1 Preintegration Transcription by Using Rev-Dependent Rev-CEM Cells Reveals a Sizable Transcribing DNA Population Comparable to That from Proviral Templates. J. Virol. 83: 8662-8673 [Abstract] [Full Text]  
  • Arfi, V., Lienard, J., Nguyen, X.-N., Berger, G., Rigal, D., Darlix, J.-L., Cimarelli, A. (2009). Characterization of the Behavior of Functional Viral Genomes during the Early Steps of Human Immunodeficiency Virus Type 1 Infection. J. Virol. 83: 7524-7535 [Abstract] [Full Text]  
  • Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R. (2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev. 73: 211-232 [Abstract] [Full Text]  
  • Keedy, K. S., Archin, N. M., Gates, A. T., Espeseth, A., Hazuda, D. J., Margolis, D. M. (2009). A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression. J. Virol. 83: 4749-4756 [Abstract] [Full Text]  
  • Naito, T., Izumi, K., Kodama, E., Sakagami, Y., Kajiwara, K., Nishikawa, H., Watanabe, K., Sarafianos, S. G., Oishi, S., Fujii, N., Matsuoka, M. (2009). SC29EK, a Peptide Fusion Inhibitor with Enhanced {alpha}-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide. Antimicrob. Agents Chemother. 53: 1013-1018 [Abstract] [Full Text]  
  • Izumi, K., Kodama, E., Shimura, K., Sakagami, Y., Watanabe, K., Ito, S., Watabe, T., Terakawa, Y., Nishikawa, H., Sarafianos, S. G., Kitaura, K., Oishi, S., Fujii, N., Matsuoka, M. (2009). Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20. J. Biol. Chem. 284: 4914-4920 [Abstract] [Full Text]  
  • Khatua, A. K., Taylor, H. E., Hildreth, J. E. K., Popik, W. (2009). Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells. J. Virol. 83: 512-521 [Abstract] [Full Text]  
  • Watashi, K., Khan, M., Yedavalli, V. R. K., Yeung, M. L., Strebel, K., Jeang, K.-T. (2008). Human Immunodeficiency Virus Type 1 Replication and Regulation of APOBEC3G by Peptidyl Prolyl Isomerase Pin1. J. Virol. 82: 9928-9936 [Abstract] [Full Text]  
  • Baugh, L. L., Garcia, J. V., Foster, J. L. (2008). Functional Characterization of the Human Immunodeficiency Virus Type 1 Nef Acidic Domain. J. Virol. 82: 9657-9667 [Abstract] [Full Text]  
  • Tsibris, A. M. N., Sagar, M., Gulick, R. M., Su, Z., Hughes, M., Greaves, W., Subramanian, M., Flexner, C., Giguel, F., Leopold, K. E., Coakley, E., Kuritzkes, D. R. (2008). In Vivo Emergence of Vicriviroc Resistance in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Subject. J. Virol. 82: 8210-8214 [Abstract] [Full Text]  
  • Watson, K. M., Buckheit, C. E., Buckheit, R. W. Jr. (2008). Comparative Evaluation of Virus Transmission Inhibition by Dual-Acting Pyrimidinedione Microbicides Using the Microbicide Transmission and Sterilization Assay. Antimicrob. Agents Chemother. 52: 2787-2796 [Abstract] [Full Text]  
  • Fujita, M., Otsuka, M., Miyoshi, M., Khamsri, B., Nomaguchi, M., Adachi, A. (2008). Vpx Is Critical for Reverse Transcription of the Human Immunodeficiency Virus Type 2 Genome in Macrophages. J. Virol. 82: 7752-7756 [Abstract] [Full Text]  
  • Veazey, R. S., Ketas, T. A., Klasse, P. J., Davison, D. K., Singletary, M., Green, L. C., Greenberg, M. L., Moore, J. P. (2008). Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249. Proc. Natl. Acad. Sci. USA 105: 10531-10536 [Abstract] [Full Text]  
  • Fukui, Y., Shindoh, K., Yamamoto, Y., Koyano, S., Kosugi, I., Yamaguchi, T., Kurane, I., Inoue, N. (2008). Establishment of a Cell-Based Assay for Screening of Compounds Inhibiting Very Early Events in the Cytomegalovirus Replication Cycle and Characterization of a Compound Identified Using the Assay. Antimicrob. Agents Chemother. 52: 2420-2427 [Abstract] [Full Text]  
  • Lackman-Smith, C., Osterling, C., Luckenbaugh, K., Mankowski, M., Snyder, B., Lewis, G., Paull, J., Profy, A., Ptak, R. G., Buckheit, R. W. Jr., Watson, K. M., Cummins, J. E. Jr., Sanders-Beer, B. E. (2008). Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides. Antimicrob. Agents Chemother. 52: 1768-1781 [Abstract] [Full Text]  
  • Borkow, G., Lara, H. H., Covington, C. Y., Nyamathi, A., Gabbay, J. (2008). Deactivation of Human Immunodeficiency Virus Type 1 in Medium by Copper Oxide-Containing Filters. Antimicrob. Agents Chemother. 52: 518-525 [Abstract] [Full Text]  
  • Kajiwara, K., Kodama, E., Sakagami, Y., Naito, T., Matsuoka, M. (2008). Dual-Reporter Phenotypic Assay for Human Immunodeficiency Viruses. J. Clin. Microbiol. 46: 792-795 [Abstract] [Full Text]  
  • Buckheit, R. W. Jr., Hartman, T. L., Watson, K. M., Chung, S.-G., Cho, E.-H. (2008). Comparative Evaluation of the Inhibitory Activities of a Series of Pyrimidinedione Congeners That Inhibit Human Immunodeficiency Virus Types 1 and 2. Antimicrob. Agents Chemother. 52: 225-236 [Abstract] [Full Text]  
  • Monde, K., Maeda, Y., Tanaka, Y., Harada, S., Yusa, K. (2007). Gp120 V3-dependent Impairment of R5 HIV-1 Infectivity Due to Virion-incorporated CCR5. J. Biol. Chem. 282: 36923-36932 [Abstract] [Full Text]  
  • Hubner, W., Chen, P., Portillo, A. D., Liu, Y., Gordon, R. E., Chen, B. K. (2007). Sequence of Human Immunodeficiency Virus Type 1 (HIV-1) Gag Localization and Oligomerization Monitored with Live Confocal Imaging of a Replication-Competent, Fluorescently Tagged HIV-1. J. Virol. 81: 12596-12607 [Abstract] [Full Text]  
  • Khurana, S., Krementsov, D. N., de Parseval, A., Elder, J. H., Foti, M., Thali, M. (2007). Human Immunodeficiency Virus Type 1 and Influenza Virus Exit via Different Membrane Microdomains. J. Virol. 81: 12630-12640 [Abstract] [Full Text]  
  • Li, X.-Y., Guo, F., Zhang, L., Kleiman, L., Cen, S. (2007). APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription. J. Biol. Chem. 282: 32065-32074 [Abstract] [Full Text]  
  • Hazen, R., Harvey, R., Ferris, R., Craig, C., Yates, P., Griffin, P., Miller, J., Kaldor, I., Ray, J., Samano, V., Furfine, E., Spaltenstein, A., Hale, M., Tung, R., St. Clair, M., Hanlon, M., Boone, L. (2007). In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV. Antimicrob. Agents Chemother. 51: 3147-3154 [Abstract] [Full Text]  
  • Klewitz, C., Klenk, H.-D., ter Meulen, J. (2007). Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity. J. Gen. Virol. 88: 2320-2328 [Abstract] [Full Text]  
  • Altenburg, J. D., Broxmeyer, H. E., Jin, Q., Cooper, S., Basu, S., Alkhatib, G. (2007). A Naturally Occurring Splice Variant of CXCL12/Stromal Cell-Derived Factor 1 Is a Potent Human Immunodeficiency Virus Type 1 Inhibitor with Weak Chemotaxis and Cell Survival Activities. J. Virol. 81: 8140-8148 [Abstract] [Full Text]  
  • Dwyer, J. J., Wilson, K. L., Davison, D. K., Freel, S. A., Seedorff, J. E., Wring, S. A., Tvermoes, N. A., Matthews, T. J., Greenberg, M. L., Delmedico, M. K. (2007). Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus. Proc. Natl. Acad. Sci. USA 104: 12772-12777 [Abstract] [Full Text]  
  • Sundstrom, J. B., Ellis, J. E., Hair, G. A., Kirshenbaum, A. S., Metcalfe, D. D., Yi, H., Cardona, A. C., Lindsay, M. K., Ansari, A. A. (2007). Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109: 5293-5300 [Abstract] [Full Text]  
  • Campbell, G. R., Watkins, J. D., Singh, K. K., Loret, E. P., Spector, S. A. (2007). Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from Monocytes. J. Virol. 81: 5919-5928 [Abstract] [Full Text]  
  • Rosenbluh, J., Hayouka, Z., Loya, S., Levin, A., Armon-Omer, A., Britan, E., Hizi, A., Kotler, M., Friedler, A., Loyter, A. (2007). Interaction between HIV-1 Rev and Integrase Proteins: A BASIS FOR THE DEVELOPMENT OF ANTI-HIV PEPTIDES. J. Biol. Chem. 282: 15743-15753 [Abstract] [Full Text]  
  • Hayouka, Z., Rosenbluh, J., Levin, A., Loya, S., Lebendiker, M., Veprintsev, D., Kotler, M., Hizi, A., Loyter, A., Friedler, A. (2007). Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc. Natl. Acad. Sci. USA 104: 8316-8321 [Abstract] [Full Text]  
  • Ao, Z., Huang, G., Yao, H., Xu, Z., Labine, M., Cochrane, A. W., Yao, X. (2007). Interaction of Human Immunodeficiency Virus Type 1 Integrase with Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication. J. Biol. Chem. 282: 13456-13467 [Abstract] [Full Text]  
  • Thomas, J. A., Ott, D. E., Gorelick, R. J. (2007). Efficiency of Human Immunodeficiency Virus Type 1 Postentry Infection Processes: Evidence against Disproportionate Numbers of Defective Virions. J. Virol. 81: 4367-4370 [Abstract] [Full Text]  
  • Aguiar, R. S., Costa, L. J., Pereira, H. S., Brindeiro, R. M., Tanuri, A. (2007). Development of a New Methodology for Screening of Human Immunodeficiency Virus Type 1 Microbicides Based on Real-Time PCR Quantification. Antimicrob. Agents Chemother. 51: 638-644 [Abstract] [Full Text]  
  • Chiba-Mizutani, T., Miura, H., Matsuda, M., Matsuda, Z., Yokomaku, Y., Miyauchi, K., Nishizawa, M., Yamamoto, N., Sugiura, W. (2007). Use of New T-Cell-Based Cell Lines Expressing Two Luciferase Reporters for Accurately Evaluating Susceptibility to Anti-Human Immunodeficiency Virus Type 1 Drugs. J. Clin. Microbiol. 45: 477-487 [Abstract] [Full Text]  
  • Guo, F., Cen, S., Niu, M., Saadatmand, J., Kleiman, L. (2006). Inhibition of Formula-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication. J. Virol. 80: 11710-11722 [Abstract] [Full Text]  
  • Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., Fujita, M., Uchiyama, T., Adachi, A. (2006). Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. USA 103: 16959-16964 [Abstract] [Full Text]  
  • Sagar, M., Wu, X., Lee, S., Overbaugh, J. (2006). Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity. J. Virol. 80: 9586-9598 [Abstract] [Full Text]  
  • Finzi, A., Brunet, A., Xiao, Y., Thibodeau, J., Cohen, E. A. (2006). Major Histocompatibility Complex Class II Molecules Promote Human Immunodeficiency Virus Type 1 Assembly and Budding to Late Endosomal/Multivesicular Body Compartments. J. Virol. 80: 9789-9797 [Abstract] [Full Text]  
  • Kazmi, S. H., Naglik, J. R., Sweet, S. P., Evans, R. W., O'Shea, S., Banatvala, J. E., Challacombe, S. J. (2006). Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids. CVI 13: 1111-1118 [Abstract] [Full Text]  
  • Zhang, Z., Walker, M., Xu, W., Shim, J. H., Girardet, J.-L., Hamatake, R. K., Hong, Z. (2006). Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.. Antimicrob. Agents Chemother. 50: 2772-2781 [Abstract] [Full Text]  
  • Hu, Z., Giguel, F., Hatano, H., Reid, P., Lu, J., Kuritzkes, D. R. (2006). Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1. J. Virol. 80: 7020-7027 [Abstract] [Full Text]  
  • Saini, M., Potash, M. J. (2006). Novel Activities of Cyclophilin A and Cyclosporin A during HIV-1 Infection of Primary Lymphocytes and Macrophages. J. Immunol. 177: 443-449 [Abstract] [Full Text]  
  • Mandal, D., Dash, C., Le Grice, S. F. J., Prasad, V. R. (2006). Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function. Nucleic Acids Res 34: 2853-2863 [Abstract] [Full Text]  
  • Roy, B. B., Hu, J., Guo, X., Russell, R. S., Guo, F., Kleiman, L., Liang, C. (2006). Association of RNA Helicase A with Human Immunodeficiency Virus Type 1 Particles. J. Biol. Chem. 281: 12625-12635 [Abstract] [Full Text]  
  • Mendoza, R., Anderson, M. M., Overbaugh, J. (2006). A putative thiamine transport protein is a receptor for feline leukemia virus subgroup a.. J. Virol. 80: 3378-3385 [Abstract] [Full Text]  
  • Davis, M. R., Jiang, J., Zhou, J., Freed, E. O., Aiken, C. (2006). A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41. J. Virol. 80: 2405-2417 [Abstract] [Full Text]  
  • O'Neill, E., Kuo, L. S., Krisko, J. F., Tomchick, D. R., Garcia, J. V., Foster, J. L. (2006). Dynamic Evolution of the Human Immunodeficiency Virus Type 1 Pathogenic Factor, Nef. J. Virol. 80: 1311-1320 [Abstract] [Full Text]  
  • Gatanaga, H., Das, D., Suzuki, Y., Yeh, D. D., Hussain, K. A., Ghosh, A. K., Mitsuya, H. (2006). Altered HIV-1 Gag Protein Interactions with Cyclophilin A (CypA) on the Acquisition of H219Q and H219P Substitutions in the CypA Binding Loop. J. Biol. Chem. 281: 1241-1250 [Abstract] [Full Text]  
  • Nguyen, D. G., Wolff, K. C., Yin, H., Caldwell, J. S., Kuhen, K. L. (2006). "UnPAKing" Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening To Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection. J. Virol. 80: 130-137 [Abstract] [Full Text]  
  • Hazen, R. J., Harvey, R. J., St. Clair, M. H., Ferris, R. G., Freeman, G. A., Tidwell, J. H., Schaller, L. T., Cowan, J. R., Short, S. A., Romines, K. R., Chan, J. H., Boone, L. R. (2005). Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance. Antimicrob. Agents Chemother. 49: 4465-4473 [Abstract] [Full Text]  
  • Ferris, R. G., Hazen, R. J., Roberts, G. B., St. Clair, M. H., Chan, J. H., Romines, K. R., Freeman, G. A., Tidwell, J. H., Schaller, L. T., Cowan, J. R., Short, S. A., Weaver, K. L., Selleseth, D. W., Moniri, K. R., Boone, L. R. (2005). Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrob. Agents Chemother. 49: 4046-4051 [Abstract] [Full Text]  
  • Yang, X., Kurteva, S., Ren, X., Lee, S., Sodroski, J. (2005). Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1. J. Virol. 79: 12132-12147 [Abstract] [Full Text]  
  • Mink, M., Mosier, S. M., Janumpalli, S., Davison, D., Jin, L., Melby, T., Sista, P., Erickson, J., Lambert, D., Stanfield-Oakley, S. A., Salgo, M., Cammack, N., Matthews, T., Greenberg, M. L. (2005). Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro. J. Virol. 79: 12447-12454 [Abstract] [Full Text]  
  • Abram, M. E., Parniak, M. A. (2005). Virion Instability of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Mutated in the Protease Cleavage Site between RT p51 and the RT RNase H Domain. J. Virol. 79: 11952-11961 [Abstract] [Full Text]  
  • Chen, R., Yokoyama, M., Sato, H., Reilly, C., Mansky, L. M. (2005). Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies. J. Virol. 79: 12045-12057 [Abstract] [Full Text]  
  • Mulky, A., Kappes, J. C. (2005). Analysis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Subunit Structure/Function in the Context of Infectious Virions and Human Target Cells. Antimicrob. Agents Chemother. 49: 3762-3769 [Abstract] [Full Text]  
  • Cao, J., Isaacson, J., Patick, A. K., Blair, W. S. (2005). High-Throughput Human Immunodeficiency Virus Type 1 (HIV-1) Full Replication Assay That Includes HIV-1 Vif as an Antiviral Target. Antimicrob. Agents Chemother. 49: 3833-3841 [Abstract] [Full Text]  
  • Doria-Rose, N. A., Learn, G. H., Rodrigo, A. G., Nickle, D. C., Li, F., Mahalanabis, M., Hensel, M. T., McLaughlin, S., Edmonson, P. F., Montefiori, D., Barnett, S. W., Haigwood, N. L., Mullins, J. I. (2005). Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope. J. Virol. 79: 11214-11224 [Abstract] [Full Text]  
  • Yusa, K., Maeda, Y., Fujioka, A., Monde, K., Harada, S. (2005). Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 Loop Library. J. Biol. Chem. 280: 30083-30090 [Abstract] [Full Text]  
  • Mascola, J. R., D'Souza, P., Gilbert, P., Hahn, B. H., Haigwood, N. L., Morris, L., Petropoulos, C. J., Polonis, V. R., Sarzotti, M., Montefiori, D. C. (2005). Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines. J. Virol. 79: 10103-10107 [Full Text]  
  • Madsen, J. M., Stoltzfus, C. M. (2005). An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication. J. Virol. 79: 10478-10486 [Abstract] [Full Text]  
  • Resch, W., Parkin, N., Watkins, T., Harris, J., Swanstrom, R. (2005). Evolution of Human Immunodeficiency Virus Type 1 Protease Genotypes and Phenotypes In Vivo under Selective Pressure of the Protease Inhibitor Ritonavir. J. Virol. 79: 10638-10649 [Abstract] [Full Text]  
  • Kim, Y.-S., Kim, J.-M., Jung, D.-L., Kang, J.-E., Lee, S., Kim, J. S., Seol, W., Shin, H.-C., Kwon, H. S., Van Lint, C., Hernandez, N., Hur, M.-W. (2005). Artificial Zinc Finger Fusions Targeting Sp1-binding Sites and the trans-Activator-responsive Element Potently Repress Transcription and Replication of HIV-1. J. Biol. Chem. 280: 21545-21552 [Abstract] [Full Text]  
  • Miles, L. R., Agresta, B. E., Khan, M. B., Tang, S., Levin, J. G., Powell, M. D. (2005). Effect of Polypurine Tract (PPT) Mutations on Human Immunodeficiency Virus Type 1 Replication: a Virus with a Completely Randomized PPT Retains Low Infectivity. J. Virol. 79: 6859-6867 [Abstract] [Full Text]  
  • Yang, Q.-e., Stephen, A. G., Adelsberger, J. W., Roberts, P. E., Zhu, W., Currens, M. J., Feng, Y., Crise, B. J., Gorelick, R. J., Rein, A. R., Fisher, R. J., Shoemaker, R. H., Sei, S. (2005). Discovery of Small-Molecule Human Immunodeficiency Virus Type 1 Entry Inhibitors That Target the gp120-Binding Domain of CD4. J. Virol. 79: 6122-6133 [Abstract] [Full Text]  
  • Wei, B. L., Denton, P. W., O'Neill, E., Luo, T., Foster, J. L., Garcia, J. V. (2005). Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection. J. Virol. 79: 5705-5712 [Abstract] [Full Text]  
  • Miyauchi, K., Komano, J., Yokomaku, Y., Sugiura, W., Yamamoto, N., Matsuda, Z. (2005). Role of the Specific Amino Acid Sequence of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 in Membrane Fusion. J. Virol. 79: 4720-4729 [Abstract] [Full Text]  
  • Sakaguchi, N., Kimura, T., Matsushita, S., Fujimura, S., Shibata, J., Araki, M., Sakamoto, T., Minoda, C., Kuwahara, K. (2005). Generation of High-Affinity Antibody against T Cell-Dependent Antigen in the Ganp Gene-Transgenic Mouse. J. Immunol. 174: 4485-4494 [Abstract] [Full Text]  
  • Huang, Y. T., Wright, A., Gao, X., Kulick, L., Yan, H., Lamm, M. E. (2005). Intraepithelial Cell Neutralization of HIV-1 Replication by IgA. J. Immunol. 174: 4828-4835 [Abstract] [Full Text]  
  • Speirs, C., van Nimwegen, E., Bolton, D., Zavolan, M., Duvall, M., Angleman, S., Siegel, R., Perelson, A. S., Lenardo, M. J. (2005). Analysis of Human Immunodeficiency Virus Cytopathicity by Using a New Method for Quantitating Viral Dynamics in Cell Culture. J. Virol. 79: 4025-4032 [Abstract] [Full Text]  
  • Bohne, J., Wodrich, H., Kräusslich, H.-G. (2005). Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res 33: 825-837 [Abstract] [Full Text]  
  • Morcock, D. R., Thomas, J. A., Gagliardi, T. D., Gorelick, R. J., Roser, J. D., Chertova, E. N., Bess, J. W. Jr., Ott, D. E., Sattentau, Q. J., Frank, I., Pope, M., Lifson, J. D., Henderson, L. E., Crise, B. J. (2005). Elimination of Retroviral Infectivity by N-Ethylmaleimide with Preservation of Functional Envelope Glycoproteins. J. Virol. 79: 1533-1542 [Abstract] [Full Text]  
  • Nameki, D., Kodama, E., Ikeuchi, M., Mabuchi, N., Otaka, A., Tamamura, H., Ohno, M., Fujii, N., Matsuoka, M. (2005). Mutations Conferring Resistance to Human Immunodeficiency Virus Type 1 Fusion Inhibitors Are Restricted by gp41 and Rev-Responsive Element Functions. J. Virol. 79: 764-770 [Abstract] [Full Text]  
  • Boulanger, M.-C., Liang, C., Russell, R. S., Lin, R., Bedford, M. T., Wainberg, M. A., Richard, S. (2005). Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression. J. Virol. 79: 124-131 [Abstract] [Full Text]  
  • Ambrose, Z., Boltz, V., Palmer, S., Coffin, J. M., Hughes, S. H., KewalRamani, V. N. (2004). In Vitro Characterization of a Simian Immunodeficiency Virus-Human Immunodeficiency Virus (HIV) Chimera Expressing HIV Type 1 Reverse Transcriptase To Study Antiviral Resistance in Pigtail Macaques. J. Virol. 78: 13553-13561 [Abstract] [Full Text]  
  • Dave, R. S., Pomerantz, R. J. (2004). Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains. J. Virol. 78: 13687-13696 [Abstract] [Full Text]  
  • Beriault, V., Clement, J.-F., Levesque, K., LeBel, C., Yong, X., Chabot, B., Cohen, E. A., Cochrane, A. W., Rigby, W. F. C., Mouland, A. J. (2004). A Late Role for the Association of hnRNP A2 with the HIV-1 hnRNP A2 Response Elements in Genomic RNA, Gag, and Vpr Localization. J. Biol. Chem. 279: 44141-44153 [Abstract] [Full Text]  
  • Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C., Li, P. (2004). Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif. J. Virol. 78: 10574-10581 [Abstract] [Full Text]  
  • Kameoka, M., Nukuzuma, S., Itaya, A., Tanaka, Y., Ota, K., Ikuta, K., Yoshihara, K. (2004). RNA Interference Directed against Poly(ADP-Ribose) Polymerase 1 Efficiently Suppresses Human Immunodeficiency Virus Type 1 Replication in Human Cells. J. Virol. 78: 8931-8934 [Abstract] [Full Text]  
  • Mulky, A., Sarafianos, S. G., Arnold, E., Wu, X., Kappes, J. C. (2004). Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo. J. Virol. 78: 7089-7096 [Abstract] [Full Text]  
  • Brown, A., Moghaddam, S., Kawano, T., Cheng-Mayer, C. (2004). Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages. J. Gen. Virol. 85: 1463-1469 [Abstract] [Full Text]  
  • Yamashita, M., Emerman, M. (2004). Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells. J. Virol. 78: 5670-5678 [Abstract] [Full Text]  
  • Campbell, E. M., Nunez, R., Hope, T. J. (2004). Disruption of the Actin Cytoskeleton Can Complement the Ability of Nef To Enhance Human Immunodeficiency Virus Type 1 Infectivity. J. Virol. 78: 5745-5755 [Abstract] [Full Text]  
  • Chan, W.-E., Wang, Y.-L., Lin, H.-H., Chen, S. S.-L. (2004). Effect of Extension of the Cytoplasmic Domain of Human Immunodeficiency Type 1 Virus Transmembrane Protein gp41 on Virus Replication. J. Virol. 78: 5157-5169 [Abstract] [Full Text]  
  • Lu, J., Sista, P., Giguel, F., Greenberg, M., Kuritzkes, D. R. (2004). Relative Replicative Fitness of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide (T-20). J. Virol. 78: 4628-4637 [Abstract] [Full Text]  
  • Chackerian, B., Briglio, L., Albert, P. S., Lowy, D. R., Schiller, J. T. (2004). Induction of Autoantibodies to CCR5 in Macaques and Subsequent Effects upon Challenge with an R5-Tropic Simian/Human Immunodeficiency Virus. J. Virol. 78: 4037-4047 [Abstract] [Full Text]  
  • Saenz, D. T., Loewen, N., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M., Poeschla, E. M. (2004). Unintegrated Lentivirus DNA Persistence and Accessibility to Expression in Nondividing Cells: Analysis with Class I Integrase Mutants. J. Virol. 78: 2906-2920 [Abstract] [Full Text]  
  • Ao, Z., Yao, X., Cohen, E. A. (2004). Assessment of the Role of the Central DNA Flap in Human Immunodeficiency Virus Type 1 Replication by Using a Single-Cycle Replication System. J. Virol. 78: 3170-3177 [Abstract] [Full Text]  
  • Chiu, Y.-L., Cao, H., Jacque, J.-M., Stevenson, M., Rana, T. M. (2004). Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference Directed against Human Transcription Elongation Factor P-TEFb (CDK9/CyclinT1). J. Virol. 78: 2517-2529 [Abstract] [Full Text]  
  • Dooher, J. E., Lingappa, J. R. (2004). Conservation of a Stepwise, Energy-Sensitive Pathway Involving HP68 for Assembly of Primate Lentivirus Capsids in Cells. J. Virol. 78: 1645-1656 [Abstract] [Full Text]  
  • Khan, M., Jin, L., Huang, M. B., Miles, L., Bond, V. C., Powell, M. D. (2004). Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Virions Containing HIV-2 or Simian Immunodeficiency Virus Nef Are Resistant to Cyclosporine Treatment. J. Virol. 78: 1843-1850 [Abstract] [Full Text]  
  • Collins, J. A., Thompson, M. G., Paintsil, E., Ricketts, M., Gedzior, J., Alexander, L. (2004). Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants. J. Virol. 78: 603-611 [Abstract] [Full Text]  
  • Zhou, J., Yuan, X., Dismuke, D., Forshey, B. M., Lundquist, C., Lee, K.-H., Aiken, C., Chen, C. H. (2004). Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Specific Targeting of the Final Step of Virion Maturation. J. Virol. 78: 922-929 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»